Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stanford researchers uncover mystery behind how skull plates fuse

10.04.2003


Stanford University Medical Center researchers have identified a protein responsible for ensuring correct skull growth in newborn mice. The protein, called Noggin, inhibits fusion of bony plates in the skull until developmentally appropriate. The scientists hope that Noggin may one day replace surgery as a way to treat premature skull fusion in infants.



"About 1 in 2,000 children has growth plates in their skull that fuse prematurely," said Michael Longaker, MD. "The brain is rapidly expanding in size during the first two years of life. If the brain’s container - the skull - can’t expand in a similar fashion, you have a big problem." Left untreated, the condition can lead to mental retardation, blindness and seizures, as well as a severely misshapen head.

Longaker, a pediatric craniofacial surgeon at Lucile Packard Children’s Hospital and a professor of surgery at the School of Medicine, can correct the defect by removing sections of fused bone from an infant’s skull. But the operation is complex. And because it’s difficult to accurately predict how much room is needed for expansion, the procedure may need to be repeated as the brain grows.


At first, Longaker and his colleagues suspected that the root of the problem was the inappropriate expression of proteins that stimulate bone growth in the skull. They began comparing when and where these proteins were produced, but they started on the wrong track.

"It’s not as simple as promoting bone induction," said Longaker, the principal investigator of the research, which is published in the April 10 issue of Nature. "It turns out that the inhibitors are equally important. We had been missing the point."

The researchers discovered that the bone-promoting proteins are present between all the skull growth plates in mice: those that are actively fusing and those that are not. In contrast, Noggin, a known inhibitor of bone formation, was found only between plates that remained open. The scientists began to suspect that, like a testy chaperone at a high school dance, Noggin keeps the two edges of the skull apart. And like anxious teenagers, the bones reach out to each other when Noggin is removed from the mix.

Noggin’s new role in skull fusion was confirmed dramatically when the scientists injected a Noggin-producing virus between the bone plates along mice foreheads. The plates, which normally would have fused, remained open. This resulted in the animals developing blunt muzzles and wide-set eyes.

Although the results were clear, there was another mystery to be solved. In a seemingly futile loop, the very bone-promoting protein required for fusion also induced Noggin production. Then the researchers found that over-expression of another protein, called FGF2, inhibited Noggin expression in cell culture. The finding correlated with the fact that some human disorders characterized by premature skull fusion are caused by mutations in a receptor for FGF2 that kick the protein into overdrive. These mutants also turned off Noggin expression.

"We had been wondering how FGF2, which is involved in promoting new blood vessels, stimulated bone formation," said Longaker. "Now we know that it works, in part, by decreasing the amounts of inhibitors of bone formation."

The scientists are now working to understand how FGF2 decreases Noggin production, with an eye to a less-invasive treatment for infants with premature fusion. But such treatment would likely require early diagnosis of any problems.

"Can Noggin unlock an existing bone bridge? That would be a tall order," said Longaker. "But if premature fusion could be diagnosed before birth, a window of therapy could present itself." He envisions a day when sophisticated prenatal ultrasound or genetic testing could identify infants at risk before fusion began. By injecting Noggin-producing cells or viruses into the breach between growth plates, physicians could stave off inappropriate fusion until the brain finished expanding.

"Unlike some gene therapy challenges, we wouldn’t need to express Noggin for the life of the child," said Longaker. "The first two years would be adequate." Such a treatment would represent a huge leap over existing therapy. "Craniofacial surgery is more of a chisel-and-saw approach," he added. "We’ve had technical improvements, but it hasn’t really evolved. This finding represents a biomolecular approach that may re-establish normal growth and appearance of the skull, which is the most important research outcome."

Longaker’s colleagues include Stephen Warren, MD, of Stanford; Lisa Brunet, PhD, and Richard Harland, PhD, of the University of California-Berkeley; and Aris Economides, PhD, of Regeneron Pharmaceuticals, Inc, in Tarrytown, NY. Noggin was first identified by Harland in 1992 as a protein that guides tissue fate in developing frog embryos.


Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. .For more information, please visit the Office of Communication & Public Affairs Web site at http://mednews.stanford.edu/ and the Lucile Packard Children’s Hospital Web site at http://www.lpch.org/.

Krista Conger | EurekAlert!
Further information:
http://med-www.stanford.edu/MedCenter/MedSchool/
http://www.lpch.org/

More articles from Life Sciences:

nachricht How a mutation on the novel coronavirus has come to dominate the globe
06.07.2020 | La Jolla Institute for Immunology

nachricht Order from noise: how randomness and collective dynamics define a stem cell
06.07.2020 | Institute of Science and Technology Austria

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electrons in the fast lane

Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.

Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....

Im Focus: The lightest electromagnetic shielding material in the world

Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range – and they are unrivalled in terms of weight.

Electric motors and electronic devices generate electromagnetic fields that sometimes have to be shielded in order not to affect neighboring electronic...

Im Focus: Gentle wall contact – the right scenario for a fusion power plant

Quasi-continuous power exhaust developed as a wall-friendly method on ASDEX Upgrade

A promising operating mode for the plasma of a future power plant has been developed at the ASDEX Upgrade fusion device at Max Planck Institute for Plasma...

Im Focus: ILA Goes Digital – Automation & Production Technology for Adaptable Aircraft Production

Live event – July 1, 2020 - 11:00 to 11:45 (CET)
"Automation in Aerospace Industry @ Fraunhofer IFAM"

The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM l Stade is presenting its forward-looking R&D portfolio for the first time at...

Im Focus: AI monitoring of laser welding processes - X-ray vision and eavesdropping ensure quality

With an X-ray experiment at the European Synchrotron ESRF in Grenoble (France), Empa researchers were able to demonstrate how well their real-time acoustic monitoring of laser weld seams works. With almost 90 percent reliability, they detected the formation of unwanted pores that impair the quality of weld seams. Thanks to a special evaluation method based on artificial intelligence (AI), the detection process is completed in just 70 milliseconds.

Laser welding is a process suitable for joining metals and thermoplastics. It has become particularly well established in highly automated production, for...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International conference QuApps shows status quo of quantum technology

02.07.2020 | Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

 
Latest News

Protective antibodies identified for rare, polio-like disease in children

06.07.2020 | Health and Medicine

How a mutation on the novel coronavirus has come to dominate the globe

06.07.2020 | Life Sciences

Order from noise: how randomness and collective dynamics define a stem cell

06.07.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>